Figure 3From: Comparing treatment outcomes of different chemotherapy sequences during intensity modulated radiotherapy for advanced N-stage nasopharyngeal carcinoma patientsDistant metastasis-free survival rates of 198 advanced N-stage patients treated with different methods (RT:CCRT χ2 = 2.600, P = 0.107; RT:NACT + CCRT χ2 = 5.694, P = 0.017; RT:CCRT + AC χ2 = 3.174, P = 0.075; CCRT:NACT + CCRT χ2 = 0.427, P = 0.672; CCRT:CCRT + AC χ2 = 0.991, P = 0.320; NACT + CCRT: CCRT + AC χ2 = 0.497, P = 0.481.Back to article page